Artivion's Financial Results Teleconference Planned
Artivion, Inc. (NYSE: AORT), a prominent player in the cardiac and vascular surgery industry, is gearing up to release its third quarter 2024 financial results. This announcement is highly anticipated as the company continues to make strides in addressing aortic diseases with innovative solutions.
Key Dates for the Release
The financial results will be made available to stakeholders after market closure on a designated Thursday. This timing ensures investors have a complete picture of the company's performance for the quarter. Following the release, a teleconference call is scheduled at 4:30 p.m. ET. This session will provide an excellent opportunity for the management team, led by Pat Mackin, to share insights and answer questions from participants.
How to Access the Teleconference
Interested participants can listen to the live teleconference by dialing a dedicated number shortly before the scheduled time. For those unable to attend, a replay will be accessible shortly after the event, ensuring that everyone has the chance to catch up on the company’s updates.
Webcast and Additional Resources
In addition to the teleconference, Artivion will host a live webcast of the event. The webcast can be accessed through the Investors section of the Artivion website by selecting the relevant links. Further, an earnings press release will also be available, which will provide detailed financial data and insights into operational performance.
About Artivion, Inc.
Artivion, Inc. is headquartered in suburban Atlanta and specializes in creating innovative medical devices aimed at improving the lives of patients with aortic diseases. The company offers a diverse range of products, including aortic stent grafts and surgical sealants that cater to the challenges faced by cardiac and vascular surgeons. Artivion not only excels in product development but also maintains a robust presence in over 100 countries.
Contact Information for Inquiries
For further inquiries regarding the financial results or company operations, interested parties are encouraged to reach out to Artivion's Executive Vice President, Lance A. Berry. Contact details are readily available, and assistance is provided promptly to ensure all questions are effectively addressed.
Growth and Innovations at Artivion
Growth at Artivion has been driven by its focus on research and development, with an ongoing commitment to advancing technology in cardiac care. The company's pipeline includes state-of-the-art solutions that not only simplify procedures but also significantly enhance patient outcomes. As the healthcare landscape continues to evolve, Artivion remains at the forefront, adapting to new challenges and leveraging advancements in medical technology.
Frequently Asked Questions
1. When will Artivion announce its Q3 2024 financial results?
Artivion plans to announce its Q3 2024 financial results on November 7, 2024, after market close.
2. How can I access the teleconference call?
You can join the teleconference call by dialing the provided number just a few minutes before the call starts.
3. Who will be leading the teleconference?
The teleconference will be hosted by Pat Mackin, the Chairman, President, and CEO of Artivion.
4. Is there an option to view the webcast later?
Yes, the webcast will be available for replay on the Artivion website shortly after the event concludes.
5. What products does Artivion specialize in?
Artivion specializes in aortic disease treatments, including stent grafts, surgical sealants, and mechanical heart valves, among other products.
